Ortoma AB Series B (ORT-B) — Capital Reinvestment Ratio
Latest as of June 2025:
0.02x
Ortoma AB Series B (ORT-B) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr19.16 Million) in capital expenditures (Skr421.40K). See Ortoma AB Series B free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Skr19.16 Million
SEK
Capital Expenditures
Skr421.40K
SEK
Data as of
Jun 2025
Most recent filing
Ortoma AB Series B Capital Reinvestment Ratio (2023–2025)
This chart tracks Ortoma AB Series B's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Ortoma AB Series B (2023–2025)
Year-by-year Capital Reinvestment Ratio for Ortoma AB Series B from 2023 to 2025. For live market cap and broader valuation context, see market value of Ortoma AB Series B.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | Skr6.04 Million | Skr3.09 Million | ▼ -71.5% |
| 2023 | 1.79x | Skr13.35 Million | Skr23.94 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow